In Case You Missed It: NACDS Health Care Outlook 2023 in Chain Drug Review
The NACDS-authored column previews the policy outlook for the coming year — and what lies ahead for the future of the industry.
The NACDS-authored column previews the policy outlook for the coming year — and what lies ahead for the future of the industry.
NACDS details actions needed by Biden Administration and Congress to prevent forced rollback
Sustaining PREP Act pharmacy flexibilities through October 2024 will help keep patients and pharmacies from having to “guess” about issues related to pharmacy access.
CNBC quoted NACDS on its call for the Biden Administration to maintain patients’ access to pharmacies in the effort to keep COVID-19 and flu at bay.
Hurricane Ian struck Florida as a powerful Category 4 hurricane on September 28, leaving widespread damage in its wake. NACDS member companies have been affected by the storm and—in collaboration with public health partners and emergency preparedness authorities— are working to meet the ongoing needs of people affected by the hurricane.
NACDS engages in White House Conference with commitments and recommendations, hosts “satellite event” to extend reach of event.
As COVID-19 preparedness enters a new phase, NACDS urges continuity of policies enabling pharmacies to provide key services patients expect and need.
One month ago, NACDS RxIMPACT said it would push for congressional pharmacy tours with only 25 in-district workdays left in July and August -- and it did just that.
NACDS Total Store Expo — “Tomorrow Happens Here” — welcomes NACDS chain and supplier members back to Boston with vibrant conference schedule, opportunities for connection and collaboration.
With the 2022 NACDS Total Store Expo set to launch, the Boston Business Journal this morning published an op-ed authored by NACDS President & CEO Steven C. Anderson.